Nov 2023 $75 M Issued in a merger or acquisition $50 to $250 million 6
NantBioscience, Inc.: Private sale, Nov 2023 × Investors in this round 6 investors had bought by the notice of Nov 13, 2023: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $75 M of $75 M offered
Smallest investment taken no minimum stated
What was sold equity, debt Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Charles Kenworthy · Executive Officer, Director · Secretary James Banaag · Executive Officer · Chief Financial Officer Patrick Soon-Shiong · Executive Officer, Director · President, Chief Executive Officer Douglas Reed Maughan · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by James Banaag, Chief Financial Officer. Source: SEC Form D, newest notice filed Nov 13, 2023. Read the notice at the SEC .
equity, debt SEC Apr 2015 $10 M No. 4 $10 to $50 million 1
NantBioscience, Inc.: Raise no. 4, Apr 2015 × Investors in this round 1 investor had bought by the notice of Jun 2, 2015: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $10 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Patrick Shoon-Shiong · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Charles C. Kim, General Counsel. Source: SEC Form D and 1 amendment, newest notice filed Jun 2, 2015. Read the notice at the SEC .
equity SEC Oct 2014 $25 M No. 3 $10 to $50 million 1
NantBioscience, Inc.: Raise no. 3, Oct 2014 × Investors in this round 1 investor had bought by the notice of Oct 30, 2014: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $25 M of $100 M offered; $75 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Patrick Soon-Shiong · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Charles C. Kim, General Counsel. Source: SEC Form D, newest notice filed Oct 30, 2014. Read the notice at the SEC .
equity SEC Jul 2014 $45 M No. 2 $10 to $50 million 1
NantBioscience, Inc.: Raise no. 2, Jul 2014 × Investors in this round 1 investor had bought by the notice of Feb 6, 2015: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $45 M of $45 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Patrick Shoon-Shiong · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Charles C. Kim, General Counsel. Source: SEC Form D, newest notice filed Feb 6, 2015. Read the notice at the SEC .
equity SEC Jan 2014 $25 M No. 1 $10 to $50 million 1
NantBioscience, Inc.: Raise no. 1, Jan 2014 × Investors in this round 1 investor had bought by the notice of May 16, 2014: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $25 M of $25 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Patrick Soon-Shiong · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Charles C. Kim, General Counsel. Source: SEC Form D, newest notice filed May 16, 2014. Read the notice at the SEC .
equity SEC